Kate Therapeutics
Giselle Lopez-Echeverria is a Research Associate II at Kate Therapeutics with experience in veterinary surgery, pharmaceutical studies, and laboratory animal research. Giselle holds a Master of Laboratory Animal Science from Stanford University and a Bachelor's degree in Animal Science with Pre-Veterinary Studies. Throughout their career, Giselle has demonstrated clinical skills in anesthesia, surgery, and animal care while also participating in environmental conservation programs.
Kate Therapeutics
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.